In the latest session, Ocugen Inc (NASDAQ: OCGN) closed at $0.94 down -4.94% from its previous closing price of $0.99. In other words, the price has decreased by -$0.0489 from its previous closing price. On the day, 6132441 shares were traded.
Ratios:
For a deeper understanding of Ocugen Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.08 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 14 when Zhang Junge bought 200,278 shares for $0.50 per share. The transaction valued at 99,999 led to the insider holds 1,077,182 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 241.39M and an Enterprise Value of 194.39M.
Stock Price History:
Over the past 52 weeks, OCGN has reached a high of $1.28, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 0.6047, while the 200-Day Moving Average is calculated to be 0.5039.
Shares Statistics:
For the past three months, OCGN has traded an average of 5.08M shares per day and 15.8M over the past ten days. A total of 256.50M shares are outstanding, with a floating share count of 250.87M. Insiders hold about 2.20% of the company’s shares, while institutions hold 10.24% stake in the company. Shares short for OCGN as of Feb 15, 2024 were 24.36M with a Short Ratio of 4.80, compared to 25.95M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.50% and a Short% of Float of 12.32%.
Earnings Estimates
There are 2 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.07, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.28 and -$0.29 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.28, with 2 analysts recommending between -$0.25 and -$0.31.
